Article ID Journal Published Year Pages File Type
2543713 Journal of the American Pharmacists Association 2012 9 Pages PDF
Abstract
We recommend using the MID range based on all patients combined (−0.03 to 0.10) to interpret SF-6D scores. These estimates can be used in conjunction with other measures of efficacy to determine meaningful changes. SF-6D demonstrates potential utility in predicting minimally important improvement or worsening among patients receiving different pharmacologic medications.
Related Topics
Health Sciences Medicine and Dentistry Public Health and Health Policy
Authors
, , , , ,